Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization

Abstract

ImportanceStaphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) are important complications of surgical procedures for which prevention remains suboptimal. Contemporary data on the incidence of and etiologic factors for these infections are needed to support the development of improved preventive strategies.ObjectivesTo assess the occurrence of postoperative S aureus SSIs and BSIs and quantify its association with patient-related and contextual factors.Design, Setting, and ParticipantsThis multicenter cohort study assessed surgical patients at 33 hospitals in 10 European countries who were recruited between December 16, 2016, and September 30, 2019 (follow-up through December 30, 2019). Enrolled patients were actively followed up for up to 90 days after surgery to assess the occurrence of S aureus SSIs and BSIs. Data analysis was performed between November 20, 2020, and April 21, 2022. All patients were 18 years or older and had undergone 11 different types of surgical procedures. They were screened for S aureus colonization in the nose, throat, and perineum within 30 days before surgery (source population). Both S aureus carriers and noncarriers were subsequently enrolled in a 2:1 ratio.ExposurePreoperative S aureus colonization.Main Outcomes and MeasuresThe main outcome was cumulative incidence of S aureus SSIs and BSIs estimated for the source population, using weighted incidence calculation. The independent association of candidate variables was estimated using multivariable Cox proportional hazards regression models.ResultsIn total, 5004 patients (median [IQR] age, 66 [56-72] years; 2510 [50.2%] female) were enrolled in the study cohort; 3369 (67.3%) were S aureus carriers. One hundred patients developed S aureus SSIs or BSIs within 90 days after surgery. The weighted cumulative incidence of S aureus SSIs or BSIs was 2.55% (95% CI, 2.05%-3.12%) for carriers and 0.52% (95% CI, 0.22%-0.91%) for noncarriers. Preoperative S aureus colonization (adjusted hazard ratio [AHR], 4.38; 95% CI, 2.19-8.76), having nonremovable implants (AHR, 2.00; 95% CI, 1.15-3.49), undergoing mastectomy (AHR, 5.13; 95% CI, 1.87-14.08) or neurosurgery (AHR, 2.47; 95% CI, 1.09-5.61) (compared with orthopedic surgery), and body mass index (AHR, 1.05; 95% CI, 1.01-1.08 per unit increase) were independently associated with S aureus SSIs and BSIs.Conclusions and RelevanceIn this cohort study of surgical patients, S aureus carriage was associated with an increased risk of developing S aureus SSIs and BSIs. Both modifiable and nonmodifiable etiologic factors were associated with this risk and should be addressed in those at increased S aureus SSI and BSI risk.

Confronting a New Challenge in Plastic Surgery: MDR Infections in Patients with Chronic Wounds

“…MDR means resistance to more than three different antibiotic classes. Characterized by potential drug resistance mechanisms, these bacteria may cause life-threatening infections among immunocompromised or critically ill patients, especially diabetics [8,9]. This is because diabetic patients have a higher risk of developing chronic ulcers that lower the quality of life and have a significant impact on the healthcare system [10].…”

Exploring an Innovative Approach: Integrating Negative-Pressure Wound Therapy with Silver Nanoparticle Dressings in Skin Graft Procedures

“…Overall, the combination of NPWT and silver nanoparticle sheets proves a synergistic and beneficial effect on wound healing and graft integration. As Khansa et al reported, infected diabetic foot ulcers were proven to heal more quickly with the use of silver-coated sponges instead of plain ones, as they reduce the bacterial growth of biofilm-causing species (Pseudomonas aeruginosa and Staphylococcus aureus, even MRSA) [42,43]. The synergistic effects of silver and NPWT can be achieved by applying a silver layer underneath a standard polyurethane sponge or by utilizing a polyurethane sponge coated with silver [44].…”

Candida auris Outbreak in a Multidisciplinary Hospital in Romania during the Post-Pandemic Era: Potential Solutions and Challenges in Surveillance and Epidemiological Control

“…We present a series of cases of C. auris infections and/or colonization, reported from October 2022 to July 2023 in a public university hospital in Bucharest, mainly in the cardiovascular surgery (CVS)-associated intensive care unit (ICU). Patients who underwent surgical procedures were screened for Methicillin-resistant Staphylococcus aureus and received perioperative antibiotic prophylaxis [22]. Of the 21 reported cases with C. auris during this period, some were isolated cases-in different departments-and others met the case definition for an outbreak diagnosed during the hospitalization (Figures 1a,b and 2a,b).…”